Bright Minds Biosciences (DRUG) Other Non-Current Liabilities (2022 - 2024)
Bright Minds Biosciences (DRUG) posted Other Non-Current Liabilities of $333959.3 for Q3 2024, down 45.09% on a QoQ basis from $608187.6 in Q2 2024, and down 46.18% year-over-year from $620490.3 in Q4 2023.
Bright Minds Biosciences (DRUG) Other Non-Current Liabilities (2022 - 2024) Analysis & Trends
Bright Minds Biosciences' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $333959.3 for Q3 2024.
- Quarterly Other Non-Current Liabilities fell 46.18% year-over-year to $333959.3 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $333959.3 (down 46.18% YoY) and the FY2024 annual result came in at $333959.3, down 46.18% from the prior year.
- Other Non-Current Liabilities was $333959.3 for Q3 2024 at Bright Minds Biosciences, down from $608187.6 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $620490.3 in Q3 2023 and bottomed at $9412.1 in Q2 2022.
- A 3-year average of $516417.3 and a median of $612814.6 in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities surged 6479.42% — and 2024, when it tumbled 46.18%.
- Bright Minds Biosciences' Other Non-Current Liabilities stood at $612814.6 in 2022, then retreated by 0.29% to $611011.6 in 2023, then sank by 45.34% to $333959.3 in 2024.
- Business Quant data shows DRUG's Other Non-Current Liabilities at $333959.3 in Q3 2024, $608187.6 in Q2 2024, and $617315.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 333,959.34 |
| Jun 30, 2024 | 608,187.57 |
| Mar 31, 2024 | 617,315.00 |
| Dec 31, 2023 | 611,011.63 |
| Sep 30, 2023 | 620,490.33 |
| Jun 30, 2023 | 619,260.87 |
| Mar 31, 2023 | 615,304.59 |
| Dec 31, 2022 | 612,814.55 |
| Jun 30, 2022 | 9,412.09 |